title: Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression.
abstract: The occupation of the glycine binding-site is a prerequisite for NMDA receptor activation by glutamate. To analyze the regulation of NMDA receptor function by the glycine transporter 1 (GlyT1), we generated heterozygous constitutive GlyT1 knockout mice (GlyT1tm1.1(+/-)). These animals were fully viable. Using a newly generated antibody, the pattern of GlyT1 expression in brain was found to be unaltered in the mutants while the level of expression was strongly reduced in all brain regions, as shown immunohistochemically. In hippocampal slices the ratio of the peak amplitude of NMDA and AMPA receptor evoked excitatory postsynaptic currents (EPSCs), recorded in CA1 pyramidal cells, was significantly enhanced by 36% in Glyt1tm1.1(+/-) compared to wild-type slices. The frequency and amplitude of AMPA miniature events in Glyt1tm1.1(+/-) mice were indistinguishable from those recorded in wild type. These results provide proof that the NMDA receptor function is enhanced by a reduction of GlyT1 expression. Thus, GlyT1 function is a controlling factor for an enhancement of the NMDA receptor response. These findings are of relevance for the development of GlyT1 inhibitory drugs.
authors.affiliation: Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstr. 190, CH-8057 Zurich, Switzerland.
authors.forename: Laetitia
authors.initials: L
authors.lastname: Gabernet
authors.forename: Meike
authors.initials: M
authors.lastname: Pauly-Evers
authors.forename: Cornelia
authors.initials: C
authors.lastname: Schwerdel
authors.forename: Michèle
authors.initials: M
authors.lastname: Lentz
authors.forename: Horst
authors.initials: H
authors.lastname: Bluethmann
authors.forename: Kaspar
authors.initials: K
authors.lastname: Vogt
authors.forename: Daniela
authors.initials: D
authors.lastname: Alberati
authors.forename: Hanns
authors.initials: H
authors.lastname: Mohler
authors.forename: Detlev
authors.initials: D
authors.lastname: Boison
mesh_terms: D026921:Amino Acid Transport Systems, Neutral / Q000096:biosynthesis* / Q000187:drug effects / Q000235:genetics; D000818:Animals; D015139:Blotting, Southern; D015153:Blotting, Western; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology*; D005998:Glycine / Q000378:metabolism; D050487:Glycine Plasma Membrane Transport Proteins; D007150:Immunohistochemistry; D051379:Mice; D018345:Mice, Knockout; D009924:Organ Culture Techniques; D016133:Polymerase Chain Reaction; D018091:Receptors, AMPA / Q000187:drug effects / Q000378:metabolism; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000378:metabolism*
chemical_list: D026921:Amino Acid Transport Systems, Neutral; D018691:Excitatory Amino Acid Antagonists; D050487:Glycine Plasma Membrane Transport Proteins; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; C493267:Slc6a9 protein, mouse; D005998:Glycine